Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	27.58B
Revenue (ttm)	9.42B
Net Income (ttm)	1.15B
Shares Out	1.48B
EPS (ttm)	0.79
PE Ratio	23.61
Forward PE	21.21
Dividend	0.20 (1.08%)
Ex-Dividend Date	Jul 10, 2024

Volume	22,428,533
Average Volume	56,577,896
Open	18.70
Previous Close	18.59
Day's Range	18.48 - 19.10
52-Week Range	13.49 - 21.55
Beta	0.38
RSI	51.25
Earnings Date	Aug 29, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartere...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.